Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Gastrointestinal Cancer Channel is supported with funding from Revolution Medicines (Silver).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

Share this video  

ESSO 43 | Developing European guidelines for defining and treating oligometastatic esophagogastric cancer

Richard Hillegersberg, MD, PhD, UMC Utrecht, Utrecht, Netherlands, discusses a session on oligometastatic disease in upper gastrointestinal cancers at ESSO 43, emphasizing the OMEC-project, which aims to develop a multidisciplinary European consensus statement on the definition, diagnosis, and treatment for oligometastatic esophagogastric cancer across 50 European expert centers. He highlights the project’s multiple phases, including a randomized control trial on the duration of preoperative chemotherapy in relation to local treatment. This interview took place at the ESSO 43 congress in Antwerp, Belgium.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.